Patrick E. Burnett, M.D., Ph.D., is a distinguished dermatologist and researcher who currently holds the position of Chief Medical Officer at Arcutis Biotherapeutics, Inc. Dr. Burnett's professional journey is marked by significant contributions to the field of dermatology, particularly in the development and advancement of novel therapies for skin diseases. He earned his M.D. and Ph.D. from the University of Pennsylvania, where he also completed his dermatology residency. His dual expertise in medicine and research has positioned him as a leader in the industry, with a focus on translating scientific discoveries into practical, patient-centered solutions. At Arcutis Biotherapeutics, Dr. Burnett plays a pivotal role in steering the company's clinical development strategy. Under his leadership, Arcutis has made notable strides in advancing its pipeline of dermatology therapeutics, with a keen emphasis on addressing unmet needs in conditions such as psoriasis, atopic dermatitis, and seborrheic dermatitis. His strategic vision and deep understanding of the dermatology landscape have been instrumental in guiding the company through various stages of clinical trials and regulatory processes. Dr. Burnett's commitment to innovation and excellence is evident in the progress Arcutis has achieved under his guidance, positioning the company as a frontrunner in the development of next-generation dermatological treatments. Before joining Arcutis, Dr. Burnett held several key positions in both academic and industry settings, further enriching his expertise. He has authored numerous peer-reviewed publications and has been an active participant in professional dermatology associations, contributing to the broader scientific community. His work has not only advanced the understanding of skin diseases but also improved the quality of life for countless patients. As Chief Medical Officer at Arcutis, Dr. Burnett continues to drive the company's mission to deliver transformative therapies, leveraging his extensive experience and passion for dermatology to make a lasting impact on patient care.